Nanoparticles are engineered with ligands that bind to specific receptors on the target cells. These ligands can be antibodies, peptides, or small molecules designed to recognize and attach to cell surface markers unique to diseased cells. This specificity ensures that the therapeutic agents are delivered precisely where needed.
